[Asia Economy Reporter Oh Ju-yeon] Cell Biotech announced on the 25th that its operating profit on a consolidated basis last year was 5.8 billion KRW, a 73% decrease compared to the previous year. Sales amounted to 45.9 billion KRW, down 26.5%, and net profit for the period decreased by 64.9% to 6.8 billion KRW.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing